Welcome Letter

Dear Colleagues,

It is our great pleasure to welcome you to the Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions which will take place February 24th, 2022.

The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma treatments and to summarize the current knowledge and future directions in treatment of most common lymphomas. The lectures will be presented by international lymphoma experts.

This Conference will welcome hematologists, healthcare clinicians, hematologic oncologists, medical, radiation and surgical oncologists, physicians, oncology nurses, nurse practitioners, occupational therapists, researchers, pharmacists and other healthcare professionals working in the fields of oncology and hematology.

The Conference will focus on the following key areas:
. Genomics of lymphoma
. Novel therapies in lymphoma, including Car-T, bispecific antibodies, ADCs and NK Cars
. Current treatment paradigms of most common lymphomas and ongoing clinical trials

Share your research by submitting an abstract for e-poster presentation. Join us as a Sponsor or Exhibitor and benefit from maximum visibility and exposure to a broader audience.

We look forward to seeing you at Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions.


Izidore S. Lossos M.D.
Conference Chair


Broadcast Time Zone is Eastern Standard Time (EST)
  • All registered delegates will receive an invitation with personal link to set their profile and enter the virtual Conference platform. Your personal link will only be valid until the end of the Conference.
  • Registered delegates: If you missed the broadcast date you can watch all the presentations, symposiums and Q&A’s on the VOD page of the virtual platform. You can re-set your password if you do not recall it.
  • For any questions please contact: rosemarie@bioevents-congress.com